Comment on: Recombinant human TSH in differentiated thyroid cancer: a nuclear medicine perspective

被引：2
|
作者：
Luster, Markus [1 ]
Schlumberger, Martin [2 ]
Pacini, Furio [3 ]
机构：
[1] Univ Ulm, Dept Nucl Med, D-89081 Ulm, Germany
[2] Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, F-94805 Villejuif, France
[3] Univ Siena, Sect Endocrinol & Metab, Dept Internal Med, I-53100 Siena, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷 / 02期
关键词：
HORMONE WITHDRAWAL; RADIOIODINE THERAPY; MANAGEMENT; CARCINOMA; DOSIMETRY; ABLATION;
D O I：
10.1007/s00259-008-1013-9
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：329 / 330
页数：2
相关论文
共 50 条
  • [41] Differentiated Thyroid Cancer: Then and Now. A Personal Perspective
    Borges, Anita M.
    JOURNAL OF HEAD & NECK PHYSICIANS AND SURGEONS, 2021, 9 (02): : 69 - 72
  • [42] Quality of life changes and clinical outcomes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study
    Taieb, D.
    Sebag, F.
    Cherenko, M.
    Baumstarck-Barrau, K.
    Fortanier, C.
    Farman-Ara, B.
    De Micco, C.
    Vaillant, J.
    Thomas, S.
    Conte-Devolx, B.
    Loundou, A.
    Auquier, P.
    Henry, J. F.
    Mundler, O.
    CLINICAL ENDOCRINOLOGY, 2009, 71 (01) : 115 - 123
  • [43] Assessment of recombinant human thyrotropin application in following-up patients with well-differentiated thyroid carcinoma
    Rajkovaca, Zvezdana
    Kovacevic, Pedja
    Stanetic, Mirko
    Ristic, Sinisa
    VOJNOSANITETSKI PREGLED, 2012, 69 (11) : 941 - 946
  • [44] A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer
    Gulec, Seza A.
    Ahuja, Sukhjeet
    Avram, Anca M.
    Bernet, Victor J.
    Bourguet, Patrick
    Draganescu, Ciprian
    Elisei, Rosella
    Giovanella, Luca
    Grant, Frederick
    Greenspan, Bennett
    Hegedus, Laszlo
    Jonklaas, Jacqueline
    Kloos, Richard T.
    Luster, Markus
    Oyen, Wim J. G.
    Smit, Johannes
    Tuttle, R. Michael
    THYROID, 2021, 31 (07) : 1009 - 1019
  • [45] Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients
    Barbara Jarząb
    Daria Handkiewicz-Junak
    Józef Roskosz
    Zbigniew Puch
    Zbigniew Wygoda
    Aleksandra Kukulska
    Beata Jurecka-Lubieniecka
    Kornelia Hasse-Lazar
    Maria Turska
    Aleksander Zajusz
    European Journal of Nuclear Medicine and Molecular Imaging, 2003, 30 : 1077 - 1086
  • [46] Assesment of attainment of recommended TSH levels and levothyroxine compliance in differentiated thyroid cancer patients
    Yavuz, Dilek Gogas
    Yazan, Ceyda D.
    Hekimsoy, Zeliha
    Aydin, Kadriye
    Gokkaya, Naile
    Ersoy, Canan
    Akalin, Aysen
    Topaloglu, Omercan
    Aydogan, Berna I.
    Dilekci, Esra N. A.
    Alphan Uc, Ziynet
    Cansu, Guven B.
    Ozsari, Levent
    Iyidir, Ozlem T.
    Olgun, Mehtap E.
    Keskin, Lezzan
    Mert, Meral
    Can, Bulent
    Gungor, Kaan
    Galip, Tayfun
    Canturk, Zeynep
    Elbuken, Gulsah
    Pekkolay, Zafer
    Kutbay, Nilufer O.
    Yorulmaz, Goknur
    Kalkan, Ahmet T.
    Unsal, Yasemin A.
    Yay, Adnan
    Karagun, Baris
    Bozkur, Evin
    CLINICAL ENDOCRINOLOGY, 2022, 97 (06) : 833 - 840
  • [47] Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH
    Tala, H.
    Robbins, R.
    Fagin, J. A.
    Larson, S. M.
    Tuttle, R. M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (07) : 2105 - 2111
  • [48] Examining recombinant human TSH primed 131I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol
    Rani, Deepa
    Kaisar, Sushma
    Awasare, Sushma
    Kamaldeep
    Abhyankar, Amit
    Basu, Sandip
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (09) : 1767 - 1780
  • [49] Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis
    Fu, H.
    Ma, C.
    Tang, L.
    Wu, F.
    Liu, B.
    Wang, H.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 59 (01) : 121 - 128
  • [50] Radioactive iodine in differentiated thyroid cancer: a national database perspective
    Orosco, Ryan K.
    Hussain, Timon
    Noel, Julia E.
    Chang, David C.
    Dosiou, Chrysoula
    Mittra, Erik
    Divi, Vasu
    Orloff, Lisa A.
    ENDOCRINE-RELATED CANCER, 2019, 26 (10) : 795 - 802
12345